Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 1/20 | 0.43 |
| ▸ | PRKCG | P05129 | 1/20 | 0.43 |
| ▸ | PRKCB | P05771 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 1/20 | 0.43 |
| ▸ | PRKCH | P24723 | 1/20 | 0.43 |
| ▸ | PRKCI | P41743 | 1/20 | 0.43 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.43 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.43 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.43 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.43 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.42 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.42 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.42 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.42 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14359774 | 0.96 | TSHR (0.43) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL20873526 | 0.93 | PRKD3 (0.50) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL19528587 | 0.92 | TDP1 (0.50) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL13559673 | 0.92 | TDP1 (0.50) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL22499996 | 0.91 | PRKD3 (0.53) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL8349493 | 0.91 | PRKD3 (0.53) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL23159892 | 0.86 | TDP1 (0.48) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL31310702 | 0.86 | TDP1 (0.48) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL12789469 | 0.85 | — | — | |
| SCHEMBL28986977 | 0.85 | TDP1 (0.44) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3630057-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | Chanel Parfums Beauté (FR) | 2020-04-08 | — | — | EP | disclosed |
| EP-3463586-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | Chanel Parfums Beauté (FR) | 2019-04-10 | — | — | EP | disclosed |
| EP-3463585-A1 | PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS | Chanel Parfums Beauté (FR) | 2019-04-10 | — | — | EP | disclosed |
| EP-3150608-A1 | 2' -FLUORO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | Gilead Sciences, Inc. (US) | 2017-04-05 | — | — | EP | disclosed |
| US-8017597-B2 | Analgesic agent comprising cyclic phosphatidic acid derivative | OCHANOMIZU UNIVERSITY (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20110086820-A1 | ANALGESIC AGENT COMPRISING CYCLIC PHOSPHATIDIC ACID DERIVATIVE | OCHANOMIZU UNIVERSITY (JP) | 2011-04-14 | — | — | US | disclosed |
| US-7838670-B2 | useful for image-forming materials, IR-sensitive thermal recording materials, optical recording devices and optical film materials | FUJIFILM CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| US-20090270610-A1 | NAPHTHALOCYANINE COMPOUND AND METHOD FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2009-10-29 | — | — | US | disclosed |
| CN-1766733-A | Phototonus resin composition, spacer for display panel and display panel | JSR CORP (JP) | 2006-05-03 | — | — | CN | disclosed |
| EP-0962445-B1 | Acetylene compound, liquid crystal composition and liquid crystal element | MITSUI CHEMICALS INC (JP) | 2003-02-26 | — | — | EP | disclosed |
| EP-0751133-B1 | Pyrimidine compound, and liquid crystal composition and liquid crystal element using the same | MITSUI CHEMICALS INC (JP) | 2001-09-12 | — | — | EP | disclosed |
| US-6217793-B1 | Acetylene compound, liquid crystal composition and liquid crystal element | MITSUI CHEMICALS, INC. (JP) | 2001-04-17 | — | — | US | disclosed |
| EP-0962445-A1 | Acetylene compound, liquid crystal composition and liquid crystal element | Mitsui Chemicals, Inc. (JP) | 1999-12-08 | — | — | EP | disclosed |
| US-5770108-A | HIGH SPEED RESPONSE, MOLECULAR ORIENTATION, HIGH CONTRAST, RECEPTIVITY | MITSUI TOATSU CHEMICALS, INC. (JP) | 1998-06-23 | — | — | US | disclosed |
| EP-0751133-A1 | Pyrimidine compound, and liquid crystal composition and liquid crystal element using the same | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1997-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086820-A1 | ANALGESIC AGENT COMPRISING CYCLIC PHOSPHATIDIC ACID DERIVATIVE | PLA2G4A, PLA2G6, PLA2G2A | PRKD3 1977/4885PRKCG 1826/4885PRKCB 2807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.